Patients with Coexistence of Circulating Hepatitis B Surface Antigen and Its Antibody May Have a Strong Predisposition to Virus Reactivation During Immunosuppressive Therapy: A Hypothesis

Hepatitis B virus (HBV) reactivation is a well-recognized complication in patients who undergo immunosuppressive drug therapy. Although the recommendation of antiviral prophylaxis made by the American Gastroenterological Association in 2015 focuses on the risk stratification of different immunosuppr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Lan, Mo, Ying-Qian, Zheng, Dong-Hui, Ma, Jian-Da, Jing, Jun, Dai, Lie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742491/
https://www.ncbi.nlm.nih.gov/pubmed/29248936
http://dx.doi.org/10.12659/MSM.905033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742491/
https://www.ncbi.nlm.nih.gov/pubmed/29248936
http://dx.doi.org/10.12659/MSM.905033

Ejemplares similares